Viyash Scientific Limited (NSE:VIYASH)
India · Delayed Price · Currency is INR 254.95
+1.10 (0.43%)
Jun 19, 2026, 3:30 PM IST
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 111.1 billion as of June 18, 2026. Its market cap has increased by 131.87% in one year.
Market Cap
111.10B
Enterprise Value
115.34B
Revenue
34.20B
Ranking
n/a
PE Ratio
62.67
Stock Price
254.95
Market Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 111.10B, an increase of 31,848.72%. That is a compound annual growth rate of 30.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 111.10B | 22.50% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Piramal Pharma | 211.00B |
| Eris Lifesciences | 200.70B |
| NATCO Pharma | 159.23B |
| Cohance Lifesciences | 155.26B |
| Alembic Pharmaceuticals | 149.98B |
| Alivus Life Sciences | 131.37B |
| Strides Pharma Science | 102.39B |
| Sudeep Pharma | 95.21B |